# Forma Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/forma-therapeutics

- Industry: Biotechnology
- Headquarters: Watertown, US
- Website: www.formatherapeutics.com
- Total disclosed funding: $133M
- Latest round: Series D (Dec 19, 2019)
- Investors on record: 10

## About

Founded in 2007 and based in Massachusetts, US, Forma Therapeutics, Inc. (Forma Therapeutics) operates as a biopharmaceutical company that researches, develops, and commercializes novel therapeutics for patients with cell disease and rare blood disorders.

## Funding rounds

- Series D, Dec 19, 2019, $100M — Wellington Management, Baker Brothers Advisors, RA Capital Management, Cormorant Asset Management, Janus Henderson Investors, Samsara BioCapital
- Series B, Dec 17, 2009, $3M — Novartis Venture Fund, Lilly Ventures, SG Growth Capital
- Series B, Dec 1, 2009, $26M — Novartis Venture Fund, Lilly Ventures, SG Growth Capital, Cubist Pharmaceuticals
- Series A, Apr 14, 2008, $4M — Novartis Venture Fund

## Investors

- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series A, Series B
- Lilly Ventures (https://capitalatlas.ai/funds/lilly-ventures) — Series B
- SG Growth Capital (https://capitalatlas.ai/funds/sg-growth-capital) — Series B
- Cubist Pharmaceuticals — Series B
- Wellington Management (https://capitalatlas.ai/funds/wellington-management) — Series D
- Baker Brothers Advisors (https://capitalatlas.ai/funds/baker-brothers-advisors) — Series D
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series D
- Cormorant Asset Management (https://capitalatlas.ai/funds/cormorant-asset-management) — Series D
- Janus Henderson Investors — Series D
- Samsara BioCapital (https://capitalatlas.ai/funds/samsara-biocapital) — Series D